Jade Martinez-Pogue

Two biotechnology firms began trading on Friday after raising a combined $310 million in their initial public offerings, marking the latest in a wave of biotechs to hit the public markets.

Nigerian digital bank and financial technology startup OPay began trading publicly in the U.S. on Friday after it raised $304 million in its initial public offering steered by Davis Polk & Wardwell LLP and Simpson Thacher & Bartlett LLP.

Nigerian digital bank and financial technology startup OPay began trading publicly in the U.S. on Friday after it raised $304 million in its initial public offering steered by Davis Polk & Wardwell LLP and Simpson Thacher & Bartlett LLP.

Betting platform Kalshi, advised by Cooley LLP, on Thursday revealed that its valuation skyrocketed to $40 billion after it wrapped its latest fundraising round with $1 billion of investor commitments.

Pharmaceutical distribution company Cencora unveiled plans Wednesday to acquire American Oncology Network Inc. in a deal that values the network at an enterprise value of $2.4 billion and was built by four law firms.

Blood clot-focused biotechnology firm City Therapeutics began trading publicly Friday after raising $200 million in its upsized initial public offering steered by Goodwin Procter LLP and Cooley LLP, joining a wave of biotechnology public listings over the past few weeks.

Willkie Farr & Gallagher LLP-led Cardinal Infrastructure Group Inc. on Tuesday unveiled plans to acquire Central Florida contractor Hughes Brothers Construction Inc. in a $357.7 million deal.

Fried Frank-Led Conversant Wraps $845M Real Estate Fund

Fried Frank-Led Conversant Wraps $845M Real Estate Fund

Mortgage servicing artificial intelligence company Valon Technologies on Monday revealed that its valuation doubled to $2.3 billion after it closed its latest funding round with $150 million in tow.

$150M Series D Values Mortgage-Focused Fintech At $2.3B